Shree Radhey Gobind Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-07-2024
- Paid Up Capital ₹ 2.40 M
as on 17-07-2024
- Company Age 12 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 17-07-2024
- Revenue -41.95%
(FY 2022)
- Profit -49.69%
(FY 2022)
- Ebitda -77.52%
(FY 2022)
- Net Worth 4.44%
(FY 2022)
- Total Assets 6.95%
(FY 2022)
About Shree Radhey Gobind Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.40 M.
The company currently has active open charges totaling ₹1.00 Cr.
Sagar Khaneja and Meenu Khaneja serve as directors at the Company.
- CIN/LLPIN
U85100DL2012PTC246462
- Company No.
246462
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Shree Radhey Gobind Pharmaceuticals Private Limited offer?
Shree Radhey Gobind Pharmaceuticals Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Pharmaceutical Capsules, Anti Infective Drugs & Medicines, Antiviral Drugs, HIV Drugs, Anti Cancer Injection.
Who are the key members and board of directors at Shree Radhey Gobind Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Khaneja  | Director | 11-Dec-2017 | Current |
| Meenu Khaneja | Director | 19-Dec-2012 | Current |
Financial Performance of Shree Radhey Gobind Pharmaceuticals.
Shree Radhey Gobind Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.95% decrease. The company also saw a substantial fall in profitability, with a 49.69% decrease in profit. The company's net worth moved up by a moderate rise of 4.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Radhey Gobind Pharmaceuticals?
Unlock access to Shree Radhey Gobind Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Radicon Laboratories Limited.Active 17 years 10 monthsSagar Khaneja and Meenu Khaneja are mutual person
Shree Gobind Pharmaceuticals Private LimitedActive 18 years 10 monthsSagar Khaneja and Meenu Khaneja are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ing Vysya Bank Limited Creation Date: 15 Jul 2013 | ₹1.00 Cr | Open |
How Many Employees Work at Shree Radhey Gobind Pharmaceuticals?
Unlock and access historical data on people associated with Shree Radhey Gobind Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Radhey Gobind Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Radhey Gobind Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
